Health Press Release – Newsletter for December 3, 2010

MarketsandMarkets: U.S. Biopharmaceuticals Market Worth $144 Billion by 2016

DALLAS, December 2, 2010 – BIOPHARMA analyzes the U.S. Biopharmaceuticals Market and its growth
factors, with special emphasis on the top companies in the field and their
product pipeline. The report also analyses the current trends and focus of
the U.S. biopharmaceutical market and the challenges faced by the industry.
It also provides profiles of the major companies …. Source article on Gaea Times at  : MarketsandMarkets: U.S. Biopharmaceuticals Market Worth $144 Billion by 2016.

SUTENT(R) Receives European Approval for a New Indication in Progressive Pancreatic Neuroendocrine Tumors (NET)

First Targeted Therapy Approved for the Treatment of Pancreatic NET in Europe

NEW YORK, December 2, 2010 – Pfizer Inc. (NYSE: PFE) announced today that the European Commission has
approved SUTENT(R) (sunitinib malate) for the treatment of unresectable or
metastatic, well-differentiated pancreatic neuroendocrine tumors (NET) with
disease progression in adults. Experience with SUTENT as initial treatment is
limited in … Read the original article on Gaea Times at : SUTENT(R) Receives European Approval for a New Indication in Progressive Pancreatic Neuroendocrine Tumors (NET).

Nordion Signs Letter of Intent to Divest MDS Nordion S.A.

Best Medical International Inc. Prospective Buyer of Nordion Belgium Operations

OTTAWA, December 2, 2010 – Nordion Inc. (TSX: NDN; NYSE: NDZ), a leading provider of products and
services to the global health science market, today announced it has signed a
non-binding letter of agreement with Best Medical International Inc. for the
divestiture of MDS Nordion S.A.
…. Original source  : Nordion Signs Letter of Intent to Divest MDS Nordion S.A..

TFI Extends Pharma Team After New Account Wins

LONDON, December 2, 2010 – TFI Group, one of the UK's leading event management agencies, has seen
its pharmaceutical division grow following a number of high-profile account
wins.

The account wins are the Japanese pharmaceutical company Daiichi Sankyo
Europe, to handle their portfolio of events across Europe, and an
international biotechnology company.
… Read more : TFI Extends Pharma Team After New Account Wins.

Data on Over 50,000 UK Adults Shows Fresh, Raw Nuts and Seeds Help With Energy Levels and Overall Health

Need More Energy? Break out the Nutcracker This Christmas
LONDON, December 2, 2010 – Online nutrition profiling firm MyNutrition.co.uk has identified that
fresh, raw nuts and seeds have a significant association with high energy
levels in adults. This is good news during the festive season since fresh
nuts are easy to obtain.

MyNutrition.co.uk looked at … Read more >>.

BMEYE and PULSION Sign Licensing Agreement

BMEYE's Breakthrough Totally Noninvasive Blood Pressure and Cardiac Output Technology Will be Incorporated Into PULSION's Next Generation Patient Monitors

AMSTERDAM, December 2, 2010 – BMEYE B.V., the innovators of a totally noninvasive combined beat-to-beat
blood pressure and cardiac output monitoring system, and PULSION Medical
Systems AG, a leading specialist in minimally invasive critical care and
cardiovascular patient monitoring, …. Source  : Gaea News Network.

New Report Indicates VERILAST(TM) Technology From Smith & Nephew Orthopaedics has Lowest Revision Rate Among all Hip Replacement Materials

Database tracking more than 150,000 hip implants shows ceramicized metal devices achieve highest survivorship rate five years after surgery

MEMPHIS, Tennessee, December 2, 2010 – A newly released patient registry reports that hip replacement implants
made from ceramicized metal heads which articulate against polyethylene lined
cups have been shown to have superior survivorship compared to implants made
from … Read this article on Gaea Times at : New Report Indicates VERILAST(TM) Technology From Smith & Nephew Orthopaedics has Lowest Revision Rate Among all Hip Replacement Materials.

The Harley Medical Group Sees an Uptake in Surgery Bookings for Christmas

LONDON, December 2, 2010 – The Harley Medical Group is reporting a 35% surge in patients booking in
for surgical procedures YOY as an early present for themselves, the month
before Christmas.

Many patients are taking extended Christmas holidays to ensure a full
recovery is made before they return to work in the New …. Source article  : The Harley Medical Group Sees an Uptake in Surgery Bookings for Christmas.